Inhibition of Acyl-Coenzyme A:cholesterol acyltransferase (ACAT) activity will decrease de novo synthesis of androgens within hormone-refractory prostate cancer cells (C4-2).

抑制酰基辅酶 A：胆固醇酰基转移酶 (ACAT) 活性将减少激素难治性前列腺癌细胞 (C4-2) 内雄激素的从头合成。

• 批准号: 183148
• 负责人: Twiddy Alexis
• 金额: $ 1.27万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-02-01 至 2010-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=183148&lang=en
• 关键词: Acat; Androgen Biosynthesis; Androgen Receptor; C4-2 Cells; Cell Culture; Cholesterol; Hormone-Refractory Prostate Cancer; Lncap Cells

Not Applicable

不适用